USPTO serial 79307986
DELISA
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Jun 21, 2022
- Examiner
- STRUCK, ROBERT J
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with DELISA?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Leigh Ann Lindquist
Leigh Ann Lindquist SUGHRUE MION, PLLC2000 Pennsylvania Avenue NW, Suite 9000Washington, DC 20006UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 009 | Instruments for diagnosis, namely, scientific apparatus and instruments for measuring relative DNA, RNA and protein and parts and fittings therefor; diagnostic chips for inspecting blood plasma, namely, diagnostic apparatus for the detection of pathogens for laboratory or research use; diagnostic chips for testing blood, namely, diagnostic apparatus for the detection of pathogens for laboratory or research use; diagnostic chips for blood analysis, namely, research laboratory analyzers for measuring, testing and analyzing blood; diagnostic chips for analyzing blood plasma, namely, research laboratory analyzers for measuring, testing and analyzing blood plasma; diagnostic chips for testing sera, namely, plates, glass slides or chips having multi-well arrays that can be used in chemical analysis, biological analysis or patterning for scientific, laboratory or medical research use; diagnostic chips for sera analysis, namely, plates, glass slides or chips having multi-well arrays that can be used in chemical analysis, biological analysis or patterning for scientific, laboratory or medical research use; lab-on-a-chip for diagnostic and medical use, namely, disposable lab-on-a-chip for diagnostic and medical use, namely, bio-chips for research or scientific purposes for manipulating, controlling and analyzing laboratory samples; lab-on-a-chip for diagnostic and medical use for nucleic acid testing; chips for measurement of antibody, namely, plates, glass slides or chips having multi-well arrays that can be used in chemical analysis, biological analysis or patterning for scientific, laboratory or medical research use; biochips for diagnostic and medical use, namely, plates, glass slides or chips having multi-well arrays that can be used in chemical analysis, biological analysis or patterning for scientific, laboratory or medical research use; chips for clinical laboratory test, namely, plates, glass slides or chips having multi-well arrays that can be used in chemical analysis, biological analysis or patterning for scientific, laboratory or medical research use; diagnostic chips for pharmaceutical use, namely, plates, glass slides or chips having multi-well arrays that can be used in chemical analysis, biological analysis or patterning for scientific, laboratory or medical research use; protein chips for diagnostic and medical use, namely, plates, glass slides or chips having multi-well arrays that can be used in chemical analysis, biological analysis or patterning for scientific, laboratory or medical research use; DNA chips for diagnostic and medical use; chips for addictive disease diagnosis, namely, plates, glass slides or chips having multi-well arrays that can be used in chemical analysis, biological analysis or patterning for scientific, laboratory or medical research use; chips for tumour diagnosis, namely, plates, glass slides or chips having multi-well arrays that can be used in chemical analysis, biological analysis or patterning for scientific, laboratory or medical research use | ACTIVE | — |
| 010 | Immunoassay apparatus for medical diagnosis; medical diagnostic imaging apparatus; diagnostic imaging apparatus for medical use; blood analysis apparatus for diagnosis; in vitro diagnostic devices for medical purposes, namely, diagnostic apparatus for detection of molecular markers containing nucleic acids and diagnostic apparatus for detection of molecular markers containing proteins and for blood analysis; in vitro diagnostic devices for medical purposes, namely, ultrasound apparatuses; in vitro diagnostic devices for medical purposes for blood analysis; medical apparatus for the diagnosis of cardiovascular diseases; medical diagnostic testing instruments for use in immunoassay procedure; apparatus for carrying-out diagnostic cell-based testing for medical purposes being point-of-care system and lab-on-a-chip systems comprised of fluidic backplane, chip holders and adapters, valves, pumps, sensor units, shape memory alloy actuators and sample cartridge; apparatus for carrying-out diagnostic tests for medical purposes, namely, diagnostic apparatus for detection of molecular markers containing nucleic acids and diagnostic apparatus for detection of molecular markers containing proteins; diagnostic measuring apparatus for medical use, namely, wearable lower limb, upper limb and chest monitors for measuring and analyzing the quality of movement and motion patterns; diagnostic measuring apparatus for medical use, namely, apparatus for measuring glucose levels, weight, temperature, posture, sleep, stress levels, blood pressure, international normalized ratio, and vital signs; diagnostic measuring apparatus for medical use for detecting cancer; medical apparatus and instruments in the fields of clinical diagnosis, namely, instruments for monitoring oxymetory, gas, analysis, and vital signs; medical apparatus and instruments in the fields of clinical diagnosis, namely, flow cytometers for medical diagnostic uses, diagnostic penlights for medical purposes; remote measuring, diagnostic and monitoring apparatus for medical use, namely, medical apparatus for monitoring acidemia in patients, medical apparatus for monitoring critically ill patients, medical apparatus for monitoring septic patients, medical apparatus for detecting surgical complications; remote measuring, diagnostic and monitoring apparatus for medical use in the nature of medical apparatus for monitoring blood oxygen saturation, blood gas concentrations, blood properties and respiratory events; remote measuring, diagnostic and monitoring apparatus for medical use for monitoring body temperate, blood pressure, heart rate, respiration, oxygen saturation, exhaled oxygen, electrocardiogram, stress levels; medical diagnostic apparatus and instruments for detecting cancer, for testing for viruses, for testing DNA and RNA samples, and for analyzing and measuring electrolytes in the body; diagnostic, examination, and monitoring equipment, namely, medical diagnostic instruments for body fluid test and body fluid analysis; scanners for medical diagnosis; sensor apparatus for medical use in diagnosis; diagnostic chips for medical use, namely, a biochip for diagnosing infectious diseases, genetic diseases and cancer | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Oct 25, 2022 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Sep 30, 2022 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Sep 30, 2022 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Sep 21, 2022 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Jun 21, 2022 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Jun 21, 2022 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Apr 5, 2022 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Apr 5, 2022 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Mar 16, 2022 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Feb 24, 2022 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Feb 18, 2022 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Feb 18, 2022 | ALIE | ASSIGNED TO LIE | — |
| Feb 17, 2022 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Feb 17, 2022 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Feb 17, 2022 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Dec 20, 2021 | GNFN | NOTIFICATION OF FINAL REFUSAL EMAILED | — |
| Dec 20, 2021 | GNFR | FINAL REFUSAL E-MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Dec 20, 2021 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Nov 12, 2021 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Nov 12, 2021 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Nov 12, 2021 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jun 13, 2021 | RFNT | REFUSAL PROCESSED BY IB | — |
| May 27, 2021 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| May 27, 2021 | RFRR | REFUSAL PROCESSED BY MPU | — |
| May 25, 2021 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| May 24, 2021 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| May 12, 2021 | DOCK | ASSIGNED TO EXAMINER | — |
| Apr 9, 2021 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Apr 5, 2021 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Apr 1, 2021 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |